Neurothrombectomy France
- Conditions
- Cerebral Artery Occlusion
- Registration Number
- NCT02880579
- Lead Sponsor
- Nantes University Hospital
- Brief Summary
The Ischemic Brain Vascular Accident (CVA) is a major public health issue. An Early and appropriate charging anyone with stroke is essential to reduce mortality, reduce dependency and promote recovery of autonomy. Intravenous fibrinolysis in patients with cerebral infarction (NINDS 1995), is reserved for a small proportion of highly selected patients. It therefore remains a significant therapeutic challenge, especially for patients with against-indications to fibrinolysis or in whom there is no immediate benefit. For twenty years of mechanical devices have been developed to remove, as quickly as possible, the cause of intracranial arterial occlusion and allow restoration of blood flow before brain damage is irreversible.
NTF The protocol is part of the evaluation process of our clinical practices recommended by the National Health Authority (HAS), in the specific context of mechanical thrombectomy performed in French centers of interventional neuroradiology working with neurovascular units (A V).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 230
- Signature of the information notice by the patient or his legal representative
- Age> 18 years
- Clinical and imaging consistent with ischemic stroke whose symptoms start back within 8h
- Thrombosis (TICI 0 or 1) of the carotid T, M1, M1-M2 bifurcation of the basilar artery occlusion in TANDEM ACI / M1.
- Pregnant or lactating women
- Rapid improvement of NIHSS (gain of more than 4 points) between two pre-treatment assessments.
- ASPECT score <7 on the scanner or <5 on the diffusion-weighted imaging (DWI)
- Intracranial hemorrhage on imaging
- Inability of clinical evaluations at 3 months
- extensive lesions of the brain stem (the presence of a complete section of the brainstem hyperintense b1000)
- 0 Refusal to participate in the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical score for handicap (mRS) at 3 months
- Secondary Outcome Measures
Name Time Method presence of arterial hypertension baseline Factors of good clinical prognosis
presence of hypercholesterolemia baseline Factors of good clinical prognosis
NIHSS score baseline Factors of good clinical prognosis
influence of anesthesia on the NIHSS at 24h hemorrhagic complications at 24h unblocking rate based on the score TICI at 3 months NIHSS evaluation at 24h presence of neoplasia baseline Factors of good clinical prognosis
Influence of hemorrhagic complications on NIHSS at 3 months presence of diabetes baseline Factors of good clinical prognosis
hemorrhagic complications on postoperative imaging at 1 day physiological parameter : age baseline Factors of good clinical prognosis
presence of intracranial stenosis baseline Factors of good clinical prognosis
presence of haematological disorders baseline Factors of good clinical prognosis
ASPECTS score baseline Factors of good clinical prognosis
MRI imaging of stroke baseline Factors of good clinical prognosis
presence of coronary artery disease baseline Factors of good clinical prognosis
presence of occlusive arterial disease baseline Factors of good clinical prognosis
Influence of collaterality score on the NIHSS at 24h Influence ASPECTS score on the NIHSS at 3months